Abstract
Type 2 diabetes mellitus (T2DM) accounts for a significant proportion of hospitalizations. Hyperglycemia itself, even without a diagnosis of diabetes, is commonly encountered in acutely ill patients. Both inpatient hyperglycemia and hypoglycemia have been associated with increased short- and long-term complications. Evidence-based use of insulin and achievement of inpatient-specific glycemic targets can reduce the morbidity and mortality associated with T2DM.
Original language | English (US) |
---|---|
Title of host publication | A Case-Based Guide to Clinical Endocrinology, Third Edition |
Publisher | Springer International Publishing |
Pages | 387-398 |
Number of pages | 12 |
ISBN (Electronic) | 9783030843670 |
ISBN (Print) | 9783030843663 |
DOIs | |
State | Published - Jan 1 2022 |
Keywords
- COVID-19
- Continuous insulin infusion therapy
- Glucocorticoid-induced hyperglycemia
- Inpatient glycemic targets
- Inpatient hyperglycemia
- Type 2 diabetes mellitus
ASJC Scopus subject areas
- General Medicine